In This Section

Maximizing the Therapeutic Value of Psychedelics: Recent Preclinical Studies

Tuesday April 09, 2019

8:00 am - 10:00 am

Room W205 A
Sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by the Division for Molecular Pharmacology (MP)
Co-sponsored by the Division for Neuropharmacology (NEU)
Co-sponsored by the Division for Translational and Clinical Pharmacology (TCP)

Chair :

Clint Canal
Mercer University

Peter Hendricks
University of Alabama Birmingham

Psychedelics such as psilocybin and methylenedioxymethamphetamine are powerful psychoactive substances with overlap in both their behavioral pharmacology and molecular pharmacology. Research on these drugs is currently undergoing a renaissance. Recent studies have shown impressive efficacy in the treatment of a variety of mood and substance-use disorders. Despite these groundbreaking results, much work remains to elucidate the precise mechanisms underlying the therapeutic effects of psychedelics. Moreover, the development of new psychedelic medications that maximize therapeutic benefits, while minimizing adverse effects, is a major research goal. In this symposium, we will discuss recent findings from preclinical studies addressing these important research topics.

The Therapeutic Promise of Psychedelics
Sara Lappan - University of Alabama Birmingham

Developing Serotonin 2A Receptor Activators with Reduced Psychoactivity as New Treatments for Substance Dependence
Kevin Murnane - Mercer University

Developing a Safer Form of MDMA
William Fantegrossi - University of Arkansas for Medical Research

Psychedelics are Powerful Anti-inflammatory Therapeutics
Charles Nichols - LSU Health Sciences Center

Last Updated: August 15, 2019
Key Dates
April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019

Thank you to our Annual Meeting partners:

University of Florida
Wake Forest University
Washington State University College of Pharmacy and Pharmaceutical Sciences
University of Wisconsin Molecular and Cellular Pharmacology Training Program
UT Health San Antonio
University of Minnesota

Emory University Pharmacology

PR & P
University of Michigan Medical School Pharmacology